Skip to main content


Page 1 of 18

  1. Intra-tumoral heterogeneity of 18F‐fluorodeoxyglucose (18F‐FDG) uptake has been proven to be a surrogate marker for predicting treatment outcome in various tumors. However, the value of intra-tumoral heterogeneit...

    Authors: Guang Ma, Shuhui You, Yizhao Xie, Bingxin Gu, Cheng Liu, Xichun Hu, Shaoli Song, Biyun wang and Zhongyi Yang
    Citation: Cancer Imaging 2023 23:90
  2. To construct and assess a computed tomography (CT)-based deep learning radiomics nomogram (DLRN) for predicting the pathological grade of bladder cancer (BCa) preoperatively.

    Authors: Hongzheng Song, Shifeng Yang, Boyang Yu, Na Li, Yonghua Huang, Rui Sun, Bo Wang, Pei Nie, Feng Hou, Chencui Huang, Meng Zhang and Hexiang Wang
    Citation: Cancer Imaging 2023 23:89
  3. The current study aimed to construct and validate a magnetic resonance imaging (MRI)-based radiomics nomogram to predict tumor protein p53 gene status in rectal cancer patients using machine learning.

    Authors: Xia Zhong, Jiaxuan Peng, Zhenyu Shu, Qiaowei Song and Dongxue Li
    Citation: Cancer Imaging 2023 23:88
  4. Statistical atlases can provide population-based descriptions of healthy volunteers and/or patients and can be used for region- and voxel-based analysis. This work aims to develop whole-body diffusion atlases ...

    Authors: Therese Sjöholm, Sambit Tarai, Filip Malmberg, Robin Strand, Alexander Korenyushkin, Gunilla Enblad, Håkan Ahlström and Joel Kullberg
    Citation: Cancer Imaging 2023 23:87
  5. This study aimed to investigate the ability of Al18F-NOTA-FAPI PET/CT to diagnose pancreatic carcinoma and tumor-associated inflammation with the comparison of 18F-FDG PET/CT.

    Authors: Zhehao Lyu, Wei Han, Qi Zhang, Hongyue Zhao, Shan Liu, Yan Wang, Jin He, Changjiu Zhao, Lin Tian and Peng Fu
    Citation: Cancer Imaging 2023 23:86
  6. 18Fluorine-Fluoro-deoxy-glucose (18F-FDG) positron emission tomography (PET) is widely used for diagnosing various malignant tumors and evaluating metabolic activities. Although the usefulness of 18F-FDG PET has ...

    Authors: Kyungwon Kim, Dong Kyu Kim, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Cheol Ryong Ku and Eun Jig Lee
    Citation: Cancer Imaging 2023 23:85
  7. Extranodal extension (ENE) in head and neck squamous cell carcinoma (HNSCC) correlates to poor prognoses and influences treatment strategies. Deep learning may yield promising performance of predicting ENE in ...

    Authors: Tzu-Ting Huang, Yi-Chen Lin, Chia-Heng Yen, Jui Lan, Chiun-Chieh Yu, Wei-Che Lin, Yueh-Shng Chen, Cheng-Kang Wang, Eng-Yen Huang and Shinn-Ying Ho
    Citation: Cancer Imaging 2023 23:84
  8. To develop and validate a prediction model for early recurrence of stage I lung adenocarcinoma (LUAD) that combines radiomics features based on preoperative CT with tumour spread through air spaces (STAS).

    Authors: Yuhang Wang, Yun Ding, Xin Liu, Xin Li, Xiaoteng Jia, Jiuzhen Li, Han Zhang, Zhenchun Song, Meilin Xu, Jie Ren and Daqiang Sun
    Citation: Cancer Imaging 2023 23:83
  9. This study aimed to develop and validate a model based on biparametric magnetic resonance imaging (bpMRI) for the detection of clinically significant prostate cancer (csPCa) in biopsy-naïve patients.

    Authors: Beibei Hu, Huili Zhang, Yueyue Zhang and Yongming Jin
    Citation: Cancer Imaging 2023 23:82
  10. The prostate-specific antigen (PSA) has been widely used in screening and early diagnosis of prostate cancer (PCa). However, in the PSA grey zone of 4–10 ng/ml, the sensitivity and specificity for diagnosing P...

    Authors: Jinhui Yang, Jian Li, Ling Xiao, Ming Zhou, Zhihui Fang, Yi Cai, Yongxiang Tang and Shuo Hu
    Citation: Cancer Imaging 2023 23:81
  11. The three-dimensional chemical exchange saturation transfer (3D CEST) technique is a novel and promising magnetic resonance sequence; however, its application in nasopharyngeal carcinoma (NPC) lacks sufficient...

    Authors: Wenguang Liu, Xiao Wang, Simin Xie, Weiyin Vivian Liu, Ismail Bilal Masokano, Yu Bai, Juan Chen, Linhui Zhong, Yijing Luo, Gaofeng Zhou, Wenzheng Li and Yigang Pei
    Citation: Cancer Imaging 2023 23:80
  12. Anatomical ablation, defined as thermal ablation of tumor-bearing small portal territories, may provide excellent local tumor control in peripherally-located small hepatocellular carcinomas (HCC), which has be...

    Authors: Jae Hyun Kim, Hee Soo Kim, Jeong Hee Yoon, Ijin Joo, Jung-Hwan Yoon, Yoon Jun Kim, Su Jong Yu and Jeong Min Lee
    Citation: Cancer Imaging 2023 23:78
  13. The aim of this work is to evaluate the performance of radiomics predictions for a range of molecular, genomic and clinical targets in patients with clear cell renal cell carcinoma (ccRCC) and demonstrate the ...

    Authors: Matthew R. Orton, Evan Hann, Simon J. Doran, Scott T. C. Shepherd, Derfel Ap Dafydd, Charlotte E. Spencer, José I. López, Víctor Albarrán-Artahona, Francesca Comito, Hannah Warren, Joshua Shur, Christina Messiou, James Larkin, Samra Turajlic and Dow-Mu Koh
    Citation: Cancer Imaging 2023 23:76
  14. This study was designed to investigate the use of time-dependent diffusion magnetic resonance imaging (MRI) parameters in distinguishing between glioblastomas and brain metastases.

    Authors: Kiyohisa Kamimura, Yoshiki Kamimura, Tsubasa Nakano, Tomohito Hasegawa, Masanori Nakajo, Chihiro Yamada, Kentaro Akune, Fumitaka Ejima, Takuro Ayukawa, Soichiro Ito, Hiroaki Nagano, Koji Takumi, Masatoyo Nakajo, Hiroyuki Uchida, Kazuhiro Tabata, Takashi Iwanaga…
    Citation: Cancer Imaging 2023 23:75
  15. Our study aimed to explore the potential of radiomics features derived from CT images in predicting the prognosis and response to adjuvant chemotherapy (ACT) in patients with Stage II colorectal cancer (CRC).

    Authors: Hui Zhu, Muni Hu, Yanru Ma, Xun Yao, Xiaozhu Lin, Menglei Li, Yue Li, Zhiyuan Wu, Debing Shi, Tong Tong and Haoyan Chen
    Citation: Cancer Imaging 2023 23:74
  16. Loss of muscle mass is the most common complication of end-stage liver disease and negatively affects outcomes for liver transplantation (LT) recipients. We aimed to determine the prognostic value of a fully a...

    Authors: Sae-Jin Park, Jeong Hee Yoon, Ijin Joo and Jeong Min Lee
    Citation: Cancer Imaging 2023 23:73
  17. Spinal metastasis and multiple myeloma share many overlapping conventional radiographic imaging characteristics, thus, their differentiation may be challenging. The purpose of this study was to develop and val...

    Authors: Shuai Zhang, Menghan Liu, Sha Li, Jingjing Cui, Guang Zhang and Ximing Wang
    Citation: Cancer Imaging 2023 23:72
  18. To build and validate a radiomics nomogram based on preoperative CT scans and clinical data for detecting synchronous ovarian metastasis (SOM) in female gastric cancer (GC) cases.

    Authors: Qian-Wen Zhang, Pan-Pan Yang, Yong-Jun-Yi Gao, Zhi-Hui Li, Yuan Yuan, Si-Jie Li, Shao-Feng Duan, Cheng-Wei Shao, Qiang Hao, Yong Lu, Qi Chen and Fu Shen
    Citation: Cancer Imaging 2023 23:71
  19. To compare the efficacy, overall survival (OS) and safety of drug-eluting beads-TACE (DEB-TACE) and C-TACE as initial treatment in advanced hepatocellular carcinoma (HCC) patients with main portal vein tumor t...

    Authors: Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li and Mingsheng Huang
    Citation: Cancer Imaging 2023 23:70
  20. Excellent image quality is crucial for workup of hepatocellular carcinoma (HCC) in patients with liver cirrhosis because a signature tumor signal allows for non-invasive diagnosis without histologic proof. Pho...

    Authors: Dirk Graafen, Fabian Stoehr, Moritz C. Halfmann, Tilman Emrich, Friedrich Foerster, Yang Yang, Christoph Düber, Lukas Müller and Roman Kloeckner
    Citation: Cancer Imaging 2023 23:69
  21. Percutaneous hepatic perfusion (PHP) is a palliative intraarterial therapy for unresectable hepatic malignancies. During PHP, high-dose melphalan is infused via the hepatic artery to saturate tumor in the live...

    Authors: Nadia Facchetti, Jan B. Hinrichs, Lena S. Becker, Martin A. Schneider, Roland Brüning, Jan Rademacher, Jochen Lenz, Kirsten Kudrass, Arndt Vogel, Frank K. Wacker and Cornelia L. A. Dewald
    Citation: Cancer Imaging 2023 23:68
  22. After neoadjuvant therapy, most of the lymph nodes (LNs) will shrink and disappear in patients with rectal cancer. However, LNs that are still detectable on MRI carry a risk of metastasis. This study aimed to ...

    Authors: Zhiwen Zhang, Yan Chen, Ziqiang Wen, Xuehan Wu, Yutao Que, Yuru Ma, Yunzhu Wu, Quanmeng Liu, Wenjie Fan and Shenping Yu
    Citation: Cancer Imaging 2023 23:67
  23. Pancreatic ductal carcinoma patients have a really poor prognosis given its difficult early detection and the lack of early symptoms. Digital pathology is routinely used by pathologists to diagnose the disease...

    Authors: Francisco Carrillo-Perez, Francisco M. Ortuno, Alejandro Börjesson, Ignacio Rojas and Luis Javier Herrera
    Citation: Cancer Imaging 2023 23:66
  24. There is no consensus on 3-dimensional (3D) quantification method for solid component within part-solid nodules (PSNs). This study aimed to find the optimal attenuation threshold for the 3D solid component pro...

    Authors: Jieke Liu, Chaolian Xie, Yong Li, Hao Xu, Changjiu He, Haomiao Qing and Peng Zhou
    Citation: Cancer Imaging 2023 23:65
  25. The early diagnosis of medullary thyroid carcinoma (MTC) is still a challenge in clinical practice. Based on ultrasound features, many MTC cases without suspicious characteristics are not categorized as high r...

    Authors: Luying Gao, Liyuan Ma, Xiaoyi Li, Chunhao Liu, Naishi Li, Xiaolan Lian, Weibo Xia, Ruifeng Liu, Xinlong Shi, Jiang Ji, Aonan Pan, Yu Xia and Yuxin Jiang
    Citation: Cancer Imaging 2023 23:64
  26. CEUS LI-RADS (Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System) has good diagnostic efficacy for differentiating hepatic carcinoma (HCC) from solid malignant tumors. However, it can be prob...

    Authors: Jianming Li, Huarong Li, Fan Xiao, Ruiqi Liu, Yixu Chen, Menglong Xue, Jie Yu and Ping Liang
    Citation: Cancer Imaging 2023 23:63
  27. In patients with cancer, the current gold standard for assessing response to treatment involves measuring cancer lesions on computed tomography (CT) imaging. The percentage change in size of specific lesions d...

    Authors: Zena Alizzi, Andrew Gogbashian, Emmanouil Karteris and Marcia Hall
    Citation: Cancer Imaging 2023 23:62
  28. The existing data on the degree of pain in patients during CT-guided percutaneous transthoracic needle biopsy (PTNB) of lung lesions are limited and the factors related to pain are unclear. In this study, we a...

    Authors: Shou-Xin Yang, Mai-Lin Chen, Lei Xie, Hai-Bin Zhu, Yu-Liang Liu, Rui-Jia Sun, Bo Zhao, Xu-Bo Deng, Xiao-Ting Li and Ying-Shi Sun
    Citation: Cancer Imaging 2023 23:61
  29. The prognosis prediction of locally advanced rectal cancer (LARC) was important to individualized treatment, we aimed to investigate the performance of ultra-high b-value DWI (UHBV-DWI) in progression risk pre...

    Authors: Guangwen Zhang, Ziliang Xu, Jianyong Zheng, Mian Wang, Jialiang Ren, Xiaocheng Wei, Yi huan and Jinsong Zhang
    Citation: Cancer Imaging 2023 23:59
  30. Pseudoprogression (PsPD) is a rare response pattern to immune checkpoint inhibitor (ICI) therapy in oncology. This study aims to reveal imaging features of PsPD, and their association to other relevant findings.

    Authors: Sebastian Mönch, Maurice M. Heimer, Michael Winkelmann, Anne Guertler, Max Schlaak, Amanda Tufman, Najib Ben Khaled, Enrico de Toni, Christoph B. Westphalen, Michael von Bergwelt-Baildon, Julien Dinkel, Philipp M. Kazmierczak, Michael Ingrisch, Nabeel Mansour, Marcus Unterrainer, Lucie Heinzerling…
    Citation: Cancer Imaging 2023 23:58
  31. The impact of molecular imaging (MI) on patient management after biochemical recurrence (BCR) following radical prostatectomy has been described in many studies. However, it is not known if MI-induced manageme...

    Authors: Samuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, Ian D Davis, Andrew M Scott, Rodney J Hicks, Ur Metser, Sue Chua, Reena Davda, Shonit Punwani, Heather Payne, Nina Tunariu, Bao Ho, Sympascho Young, Mahukpe Narcisse Ulrich Singbo, Glenn Bauman…
    Citation: Cancer Imaging 2023 23:57
  32. Lateral lymph node metastasis (LLNM) is frequent in papillary thyroid carcinoma (PTC) and is associated with a poor prognosis. This study aimed to developed a clinical-ultrasound (Clin-US) nomogram to predict ...

    Authors: Jialin Zhu, Luchen Chang, Dai Li, Bing Yue, Xueqing Wei, Deyi Li and Xi Wei
    Citation: Cancer Imaging 2023 23:55
  33. Axillary lymph node (ALN) metastasis is used to select treatment strategies and define the prognosis in breast cancer (BC) patients and is typically assessed using an invasive procedure. Noninvasive, simple, a...

    Authors: Xiaofeng Chen, Zhiqi Yang, Ruibin Huang, Yue Li, Yuting Liao, Guijin Li, Mengzhu Wang, Xiangguang Chen, Zhuozhi Dai and Weixiong Fan
    Citation: Cancer Imaging 2023 23:54
  34. Breast cancer is the most frequent cancer in women and remains the second leading cause of death in Western countries. It represents a heterogeneous group of diseases with diverse tumoral behaviour, treatment ...

    Authors: Dione Lother, Marie Robert, Elliot Elwood, Sam Smith, Nina Tunariu, Stephen R.D. Johnston, Marina Parton, Basrull Bhaludin, Thomas Millard, Kate Downey and Bhupinder Sharma
    Citation: Cancer Imaging 2023 23:53
  35. Local combined systemic therapy has been an important method for the treatment of unresectable hepatocellular carcinoma (HCC).The purpose of this study was to compare the effectiveness and safety of transarter...

    Authors: Liang Yin, Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Yu-Lin Tan, Guo-Xiang Wang, Jia-Ying Dai, Xian-Hai Zhu and Bo Jiang
    Citation: Cancer Imaging 2023 23:52
  36. The ALBI-TAE model was recently proposed as a scoring system to select suitable patients with intermediate-stage hepatocellular carcinoma (HCC) for transarterial chemoembolization (TACE). However, this scoring...

    Authors: Kittipitch Bannangkoon, Keerati Hongsakul and Teeravut Tubtawee
    Citation: Cancer Imaging 2023 23:51
  37. Enchondromas (EC) and atypical cartilaginous tumours (ACT) of the knee joint represent benign/intermediate chondromatous neoplasms of the bone that are most commonly discovered incidentally. Based on small to ...

    Authors: Johannes Nikolaus Woltsche, Maria Anna Smolle, Dieter Szolar, Marko Bergovec and Andreas Leithner
    Citation: Cancer Imaging 2023 23:50
  38. CT prediction of resectability and prognosis following neoadjuvant treatment (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) remains challenging. This study aims to determine whether addition of 18

    Authors: Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Mi Hye Yu, Jin-Young Jang and Sang Hyub Lee
    Citation: Cancer Imaging 2023 23:49
  39. CT-guided transthoracic core needle biopsy (TCNB) is a minimally invasive diagnostic procedure and a useful radiological method for diagnosing pleural lesions smaller than 10 mm in the presence of loculated pl...

    Authors: Melita Kukuljan, Ena Mršić and Eduard Oštarijaš
    Citation: Cancer Imaging 2023 23:48
  40. Authors: Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad and Håkan Ahlström
    Citation: Cancer Imaging 2023 23:46

    The original article was published in Cancer Imaging 2022 22:76

  41. Current studies indicate that fluorine-18-fluorodeoxyglucose positron emission tomography/ computed tomography ([18F]FDG PET/CT) is the most accurate imaging modality for the detection of relapsed locally advance...

    Authors: Alexander Brose, Kerstin Michalski, Juri Ruf, Marco Tosch, Susanne M. Eschmann, Mathias Schreckenberger, Jochem König, Ursula Nestle and Matthias Miederer
    Citation: Cancer Imaging 2023 23:45
  42. Chimeric antigen receptor T-cell therapy (CART) prolongs survival for patients with refractory or relapsed lymphoma. Discrepancies among different response criteria for lymphoma under CART were recently shown....

    Authors: Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, Veit L. Bücklein, Maria Ingenerf, Marcus Unterrainer, Christian Schmidt, Franziska J. Dekorsy, Peter Bartenstein, Jens Ricke, Michael von Bergwelt-Baildon, Marion Subklewe and Wolfgang G. Kunz
    Citation: Cancer Imaging 2023 23:44
  43. The worldwide increase of pancreatic ductal adenocarcinoma (PDAC), which still has one of the lowest survival rates, requires novel imaging tools to improve early detection and to refine diagnosis. Therefore, ...

    Authors: Diana Pinkert-Leetsch, Jasper Frohn, Philipp Ströbel, Frauke Alves, Tim Salditt and Jeannine Missbach-Guentner
    Citation: Cancer Imaging 2023 23:43
  44. To assess the feasibility of the cine MR feature tracking technique for the evaluation of cardiovascular-induced morphological deformation in the diagnosis of thymic epithelial tumors (TETs).

    Authors: Koji Takumi, Hiroaki Nagano, Akie Mukai, Kazuhiro Ueda, Kazuhiro Tabata and Takashi Yoshiura
    Citation: Cancer Imaging 2023 23:42
  45. Clinically significant portal hypertension (CSPH) has been identified as an important prognostic factor in patients with hepatocellular carcinoma (HCC) undergoing curative treatment. This study aimed to assess...

    Authors: Lukas Müller, Simon J. Gairing, Friedrich Foerster, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Dirk Graafen, Christoph Düber, Peter R. Galle, Roman Kloeckner and Felix Hahn
    Citation: Cancer Imaging 2023 23:40

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.636 - SNIP (Source Normalized Impact per Paper)
    1.231 - SJR (SCImago Journal Rank)

    2022 Speed
    14 days submission to first editorial decision for all manuscripts (Median)
    122 days submission to accept (Median)

    2022 Usage 
    454 Altmetric mentions 

Download journal leaflet